April 2 (Reuters) - Resonance Health Ltd (RHT) :
- TRIALSWEST IS EXPECTED TO CONTRIBUTE A$2 MILLION IN REVENUE AND A$0.67 MILLION IN EBITDA ON ANNUALISED BASIS
- ACQUISITION OF TRIALSWEST GROUP
- CONTRACTED TO ACQUIRE 100% OF TRIALSWEST PTY LTD
- WILL PAY UPFRONT CASH CONSIDERATION OF A$4 MILLION UNDER TERMS OF SHARE SALE AGREEMENT
- FURTHER A$4 MILLION MAY BE PAYABLE TO TRIALSWEST VENDORS UNDER EARNOUT ARRANGEMENT SUBJECT TO CONDITIONS
(([email protected];))
News: RHT Resonance Health Says acquisition of TrialsWest Group
Add RHT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $36.64M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 17000 | 7.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.3¢ | 80000 | 1 |
View Market Depth
| Last trade - 16.12pm 01/05/2024 (20 minute delay) ? |
| RHT (ASX) Chart |
Day chart unavailable